Pseudoephedrinechildren 6-11 years

Monographie
0produits
single ·

Noms acceptés (anglais)

4
Pseudoephedrine(common)(1S,2S)-2-Methylamino-1-phenylpropan-1-ol(proper)(alphaS)-alpha-[(1S)-1-(Methylamino)ethyl]benzenemethanol(proper)d-psi-Ephedrine(proper)

Noms acceptés (français)

4
Pseudoephedrine(common)(1S,2S)-2-Methylamino-1-phenylpropan-1-ol(proper)(alphaS)-alpha-[(1S)-1-(Methylamino)ethyl]benzenemethanol(proper)d-psi-Ephedrine(proper)

Allégations santé approuvées

4
  • Used as a decongestant (for the common cold)
  • Temporarily relieves/For the temporary relief of cold/(and) flu symptoms such as nasal congestion/sinus congestion/stuffy nose/nasal stuffiness
  • Temporarily relieves/For the temporary relief of nasal congestion/sinus congestion/stuffy nose/nasal stuffiness (due to hay fever/allergic rhinitis/the common cold)
  • Nasal decongestant

Allégations santé approuvées (Français)

4
  • Used as a decongestant (for the common cold)
  • Temporarily relieves/For the temporary relief of cold/(and) flu symptoms such as nasal congestion/sinus congestion/stuffy nose/nasal stuffiness
  • Temporarily relieves/For the temporary relief of nasal congestion/sinus congestion/stuffy nose/nasal stuffiness (due to hay fever/allergic rhinitis/the common cold)
  • Nasal decongestant

Plages de doses approuvées

1
PopulationPlage de dosesFréquence
Children 6 to 11 years30–120 milligramsper day

Mises en garde et contre-indications

8
cautionKeep out of reach of children. In case of overdose, call a poison control centre or get medical help right away (US FDA 2022; HC 2009).
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last for more than 7 days (US FDA 2022).
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician if symptoms are accompanied by a high fever that lasts longer than 3 days, the production of thick yellow/green phlegm, rash or a persistent headache.
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if the child is taking any other medications including cough and cold or weight control medications or prescription drugs, or products which contain caffeine or ephedrine (Brinker 2010; HC 2009; Mills and Bone 2005; Greenway et al. 2004; Naik and Freudenberger 2004).
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if the child has asthma, diabetes, glaucoma, heart disease, high blood pressure, kidney disease, thyroid disease, or seizure disorders or any other serious medical condition (Ando et al. 2022; Ganesh et al. 2019; Brinker 2010; HC 2009; Eccles 2006; Jorge et al. 2006; Bensky et al. 2004; Williamson 2003; Blumenthal et al. 2000; Mills and Bone 2000; Simons et al. 1996; Lambert 1987).
contraindicationDo not use in a child who is taking a monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping theMAOI drug (US FDA 2022; Brinker 2010; Eccles 2006; Mills and Bone 2005; Blumenthal et al. 2000).
adverse_reactionStop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the child experiences severe headache, confusion, visual changes/changes in vision, nervousness, dizziness, sleeplessness, difficulty or pain when urinating or allergic reactions (Ando et al. 2022; Chen 2022; US FDA 2022; Gewirtz et al. 2021; Hinduja 2020; Patel et al. 2020; Pilato 2020; Ducros 2012; Legriel et al. 2021; Mills and Bone 2005; Bensky et al. 2004; Blumenthal et al. 2000; Dickerson et al. 1978).
adverse_reactionStop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if any new symptoms appear.

Validez contre la monographie Pseudoephedrinechildren 6-11 years

Vérifiez si votre produit respecte toutes les exigences de la monographie Pseudoephedrinechildren 6-11 years — doses, allégations, mises en garde et étiquettes bilingues.

Analyser gratuitement